Merrimack Pharmaceuticals... (MACK)
NASDAQ: MACK
· Real-Time Price · USD
15.14
0.01 (0.07%)
At close: May 17, 2024, 9:59 PM
Merrimack Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -2.25 | -200.29 | -158.22 | -112.41 | -460.94 | -80.21 | -39.53 | -43.18 | -160.77 | -27.6 | -30.84 | -28.22 | -30.22 |
PEG Ratio | -0.00 | 13.95 | 5.49 | -0.36 | 5.67 | -1.58 | 1.26 | -0.17 | 2.22 | 2.92 | 1.00 | -3.19 | 0.81 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | -354.73 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.96 | 10.26 | 9.39 | 9.24 | 9.14 | 8.20 | 3.81 | 5.86 | 6.03 | 3.70 | 4.43 | 5.68 | 5.34 |
P/FCF Ratio | -162.12 | -651.79 | -869.84 | -263.2 | -492.01 | -853.27 | -190.48 | -84.97 | -239.79 | -147.7 | -145.55 | 84.09 | -192.52 |
P/OCF Ratio | -162.12 | -651.79 | -869.84 | -263.2 | -492.01 | -853.27 | -190.48 | -84.97 | -239.79 | -147.7 | -145.55 | 84.09 | -192.52 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | 0.42 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 10.78 | 43.50 | 39.14 | 47.30 | 42.39 | 33.66 | 30.42 | 31.85 | 25.91 | 26.13 | 22.25 | 20.35 | 23.76 |
Current Ratio | 10.78 | 43.50 | 39.14 | 47.30 | 42.39 | 33.66 | 30.42 | 31.85 | 25.91 | 26.13 | 22.25 | 20.35 | 23.76 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | -0.02 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -2.78 | n/a | n/a | n/a | n/a | -8.13 | -60.75 | n/a | -473 | n/a | -40.95 | n/a |
Return on Equity | -0.11 | -0.01 | -0.01 | -0.02 | n/a | -0.03 | -0.02 | -0.03 | -0.01 | -0.03 | -0.04 | -0.05 | -0.04 |
Return on Assets | -0.1 | -0.01 | -0.01 | -0.02 | n/a | -0.02 | -0.02 | -0.03 | -0.01 | -0.03 | -0.03 | -0.05 | -0.04 |
Return on Invested Capital | -0.16 | -0.03 | -0.03 | -0.03 | -0.01 | -0.03 | -0.03 | -0.03 | -0.01 | -0.03 | -0.04 | -0.05 | -0.04 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | 2.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | 1.11 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | 1.10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | 1.36 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | 1.36 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |